Skip to main content
. 2015 Jul 1;101(22):1792–1799. doi: 10.1136/heartjnl-2015-307832

Figure 1.

Figure 1

Change from baseline in 6-min walking distance (6MWD) in the subgroup of patients with pulmonary arterial hypertension associated with congenital heart disease in Pulmonary Arterial hyperTENsion sGC-stimulator Trial-1 (PATENT-1; A) and PATENT-2 (B). Data are observed values (mean±SEM).